1203results about How to "Easy to administer" patented technology

A computer executable "aggregate" task is processed by dividing it into subtasks and distributing the subtasks "on demand" to remotely located subscribing computers via a computer network. The aggregate task originates at a coordinating computer, coupled to one or more peripheral computers by appropriate communications links. The coordinating computer divides the aggregate task into multiple independent subtasks. Each peripheral computer begins to "subscribe" to the coordinating computer's aggregate task by obtaining an "idle time activation program" from the coordinating computer, and then installing the program locally. The idle time activation program which may include a screen saver, activates automatically when the subscribing computer is inactive. Continuing the subscription process, each peripheral computer requests a subtask from the coordinating computer. In response, the coordinating computer distributes different subtasks among the subscribing computers, completing the subscription process. The subscribing computers automatically work on their respective subtasks whenever they are idle, as directed by the local idle time activation program. When a subscribing computer completes its subtask, it transmits results back to the coordinating computer. When results of all subtasks have been received from subscribing computers, the coordinating computer compiles and stores these results, concluding the aggregate task.

The invention relates to pharmaceutical compositions and methods of treating inflammatory-related diseases associated with pro-inflammatory cytokine expression and/or reduced expression of anti-inflammatory cytokines. The method typically comprises administration of one or more compounds selected from isoindigo, indigo, indirubin, or derivatives thereof, such as, Meisoindigo and NATURA. Preferably the pharmaceutical composition comprises one or more compounds selected from isoindigo, indigo, indirubin, or derivatives thereof, an anti-inflammatory agent, and a pharmaceutically acceptable carrier.

The invention relates to pharmaceutical compositions and methods of treating inflammatory-related diseases associated with pro-inflammatory cytokine expression and/or reduced expression of anti-inflammatory cytokines. The method typically comprises administration of one or more compounds selected from isoindigo, indigo, indirubin, or derivatives thereof, such as, Meisoindigo and NATURA. Preferably the pharmaceutical composition comprises one or more compounds selected from isoindigo, indigo, indirubin, or derivatives thereof, an anti-inflammatory agent, and a pharmaceutically acceptable carrier.

The invention concerns a pharmaceutical and/or food composition comprising a suitable pharmaceutical and/or food vehicle and a heat shock protein and at least conformation or sequential epitopes of an antigenic structure inducing a graft versus host, an allergic or autoimmune reaction.

A forward proxy can perform identity substitutions and related services. The user provides the forward proxy with identity information, and the forward proxy presents itself to remote Internet sites on behalf of the user in the guize of the specified identity. From the remote site's point of view, the forward proxy is the machine being used by the user; the identity of the actual user machine can be hidden. Cookies are thus stored and updated at the forward proxy instead of being stored and updated at the user computer as they would be if a conventional forward proxy had been used. This helps preserve user privacy. The use of group identities, which are shared by multiple users, are also facilitated.

The invention provides a traditional Chinese medicine composition for treating colpitis mycotica, wherein the oral medicines are: 10-20 parts of viscum album, 10-20 parts of angelica, 10-20 of bighead atractylodes rhizome, 10-20 parts of motherwort, 10-20 of astragalus root, 10-20 parts of fructus zizyphi sativae, 10-20 parts of semen cuscutae, 10-20 parts of fruit of glossy privet, 10-20 of mulberry, 10-20 parts of rhizoma anemarrhenae, 10-20 of fructus rubi, 10-20 parts of Chinese magnoliavine fruit, 10-20 parts of scutellaria baicalensis, and 10-20 parts of patrinia; the external medicines are: 10-30 parts of root of Chinese pulsatilla, 10-30 parts of golden cypress, 10-30 parts of radix sophorae flavescentis, 10-30 parts of fructus cnidii, 10-30 parts of cortex dictamni, 10-30 parts of folium artemisiae argyi, 10-30 parts of clove, 10-30 parts of Chinese prickly ash, 10-30 parts of smoked plum, 10-30 parts of rhizoma smilacis glabrae, 10-30 parts of borneol, 10-30 parts of herba, and 10-30 parts of mint. The composition has fast effects of relieving itching, killing insect and degerming, strongly diminishes inflammation antibiotic property, and is high in bacteriostasis ratio, convenient for administration, easy for manufacturing and low in cost.

The invention belongs to the technical field of medicines, and provides a propranolol hydrochloride (PPL.HCL) gel which can be externally used for treating infant superficial hemangioma. The propranolol hydrochloride gel is mainly prepared from propranolol hydrochloride, gel matrix, a percutaneous penetration enhancer, a preservative, a humectant and the like. By using the propranolol hydrochloride gel, adverse reactions such as decreased heart rate, cyanosis, airway hyperresponsiveness, shortage of granular leukocytes, diarrhoea, sleep change and blood sugar reduction caused by orally taking propranolol by hemangioma patients can be reduced and even avoided, and the problems that oral dosage is not easy to control, infants inconveniently take medicines and the like are solved.

A food composition including a fish oil containing omega-3 fatty acids, a food grade acid and a flavoring agent, the food grade acid and flavoring agent neutralizing the aroma and/or flavor of the fish oil. Lemonade flavoring can be added to the composition to further neutralize the fish oil aroma and/or flavor. The food grade acid can be citric acid present in an amount of about 0.8% to about 4% by weight of the composition. The flavoring agent can be a lemon flavor ingredient present in an amount of about 0.02% to about 2% by weight, and/or a mango flavoring present in an amount of about 0.5% to about 3% by weight. The optional lemonade flavoring agent can be present in an amount of about 0.5% to about 3.5% by weight. The fish oil can be encapsulated and further immobilized in a gelatin matrix of a gummi-type product to further eliminate the fish aroma and/or flavor.

The invention discloses an external preparation for treating vitligo and a preparation and using method thereof. The external preparation comprises the following components in portion by weight: 10 to 30 portions of radix salviae miltiorrhizae, 10 to 30 portions of rhizoma drynariae, 10 to 30 portions of herba ecliptae, 10 to 30 portions of angelica, 10 to 30 portions of dodder, 10 to 30 portions of white fructus tribuli, 10 to 30 portions of purslane, 10 to 30 portions of dark plum, 10 to 30 portions of cnidium fruit, 10 to 30 portions of prepared fleece-flower root, 10 to 30 portions of safflower, 10 to 30 portions of black sesame, 10 to 30 portions of szechuan lovage rhizome, 10 to 30 portions of gromwell root, 10 to 30 portions of honeysuckle, 10 to 30 portions of malaytea scurfpea fruit, 2 to 8 portions of radix euphorbiae ebractealatae, 10 to 15 portions of toad shell and 2 to 8 portions of chilopod. The external preparation can invigorate blood circulation and eliminate freckles, inhibit epidermis sulphydryl and melatonin, and activate the activity of tyrosinase so as to recover or accelerate the generation and the transfer of melanin and recover the color element of pathological skin; and the preparation method is simple, and can obtain good economic benefit.

The invention discloses a nano-particle containing docetaxel and vitamin E TPGS (d-alpha tocopheryl polyethylene glycol 1000 succinate) and a preparation method thereof. The nano-particle containing docetaxel and vitamin E TPGS comprises the following components in parts by weight: 2-10 parts of docetaxel, 1-15 parts of vitamin E TPGS, 20-65 parts of albumin, 5-50 parts of cryoprotectant, and 2-20 parts of acidic buffer salt. Relative to an existing docetaxel commercial preparation, the nano-particle containing docetaxel and vitamin E TPGS is good in drug entrapping performance, small in toxic and side effect, high in stability, good in anti-tumor curative effect and convenient to administer; the preparation method is simple, and the production cost is low.

The invention discloses a Chinese medicinal preparation for treating anemia and a preparation method thereof. The preparation comprises the following raw materials in part by weight: 10 to 20 parts of Chinese angelica, 10 to 20 parts of root of red-rooted salvia, 10 to 20 parts of coix seed, 10 to 20 parts of dodder seed, 10 to 20 parts of prepared fleece-flower root, 10 to 20 parts of medlar, 10 to 20 parts of Chinese date, 10 to 20 parts of white paeony root, 10 to 20 parts of Chinese yam, 10 to 20 parts of yerbadetajo herb, 10 to 20 parts of suberect spatholobus stem, 10 to 20 parts of black sesame, 10 to 20 parts of mulberry, 10 to 20 parts of motherwort, 10 to 20 parts of prepared rhizome of rehmannia, 10 to 20 parts of large-headed atractylodes rhizome and 10 to 20 parts of astragalus root. Compared with the prior art, the preparation for treating the anemia has the effects of strengthening spleen and stomach, tonifying qi and producing blood. The preparation has the advantages of convenient administration, easy manufacture, low cost and the like. Because the adopted Chinese medicinal materials with different medicinal properties are scientifically compatible, the preparation can achieve the ideal treatment effect, and has the advantages of safety, low toxic and side effect and convenient use.

A strip, which is both edible and dissolvable, is provided comprising a film and a dosage of at least 2% of the reference daily intake (RDI) of at least one dietary supplement for malnutrition or to prevent/treat alcohol induced hangovers. A method for treating malnutrition and/or preventing and treating alcohol-induced hangovers using a dissolvable orally administered strip.

The invention discloses a tacrolimus eye ointment for cornea transplantation and a preparation method thereof, belongs to the field of pharmaceutical preparation and particularly relates to a tacrolimus eye precursor vesicle capsule for cornea transplantation and a preparation method thereof. The precursor vesicle capsule comprises the following raw materials in percentage by weight: 0.04-0.8% of tacrolimus, 4.0-41.0% of surfactant, 1.6-8.0% of cholesterol, 4.0-41.0% of lecithin, 1.2-30.% of alcohol, and the balance of water or 0,1% of glycerol aqueous solution or phosphate buffer with PH of 7.4, wherein the surfactant is one of span, tween, polyoxyethylene ether castor oil and poloxamer, and the alcohol is one of ethanol, isopropanol, butanol and propanol. The tacrolimus precursor vesicle capsule has limited moisture, and the storage stability of the preparation can be improved; the product organically combines the advantages of the precursor vesicle capsule, the characteristics of an eye dosing system and the indication disease of the tacrolimus drugs, so as to achieve the advantages of improving the curative effect, reducing the side effect, and bringing convenience in administration; and the preparation technique is simple and convenient and is suitable for industrial production.